Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
ROCKVILLE, Maryland, March 02, 2018 -- The American Kidney Fund (AKF), the nation’s leading nonprofit working on behalf of the 30 million Americans living with kidney disease, today added five new members to its national board of trustees:
|
|||
- Michael W. Flood, managing director and head of private equity of Northleaf Capital Partners in Toronto
- Richard T. Miller, M.D., lead thoracic surgeon and physician-in-chief, Surgery Care Center at Southcoast Hospitals Group in New Bedford, Massachusetts
- Silas P. Norman, M.D., M.P.H., clinical associate professor of internal medicine, Division of Nephrology, University of Michigan Medical School in Ann Arbor
- Lisa A. Robin, chief advocacy officer for the Federation of State Medical Boards in Washington, DC
- Michael R. Vaughan, M.D., director of medical specialties, and practice chief of nephrology at Kaiser Permanente Washington in the Pacific Northwest.
Chaired by 35-year kidney transplant recipient Robert M. Tarola, CPA, CGMA, AKF’s independent, volunteer board is a group of individuals with a broad range of professional backgrounds and personal experiences with kidney disease.
“We are so pleased to welcome our new board members, whose diversity of experience promises to enrich the board’s work in setting AKF's strategic direction for the coming years and providing appropriate oversight to ensure that we have the plans and the resources in place to carry out our vital mission,” said Tarola.
The complete list of trustees and officers, along with their biographies, can be found on AKF’s website.
About the American Kidney Fund
As the nation’s leading nonprofit working on behalf of the 30 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling 1 in 5 U.S. dialysis patients to access lifesaving medical care, including dialysis and transplantation. AKF holds the highest ratings from the nation’s charity watchdog groups, including Charity Navigator, which includes AKF on its “top 10” list of nonprofits with the longest track records of outstanding stewardship of the donated dollar, and GuideStar, which has awarded AKF its Platinum Seal of Transparency.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cb44b379-118f-4782-8e0f-38c102a6b58b
Alice Andors American Kidney Fund 240-292-7053 [email protected]
